Could psychedelics revolutionize mental health care? Psychiatrist Dr. Will Van Derveer openingly discusses his exploration of psychedelic-assisted therapies after becoming disillusioned with conventional treatments.
He details remarkable results using ketamine, psilocybin, and MDMA for conditions like PTSD and depression. With the FDA's imminent decision on rescheduling MDMA, Van Derveer provides an inside look at these groundbreaking medicines' therapeutic potential. For those struggling with mental health issues, this candid conversation may reveal new hope.
You can find Will at: Website) | Higher Practice Podcast) | Episode Transcript)
**If you LOVED this episode **you’ll also love the conversations we had with Adam Gazzaley) about cutting-edge research he’s leading in this field.
Check out our offerings & partners:
Hosted on Acast. See acast.com/privacy) for more information.
